These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33545668)

  • 1. Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis.
    McGorry PD; Mei C; Hartmann J; Yung AR; Nelson B
    Schizophr Res; 2021 Feb; 228():344-356. PubMed ID: 33545668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of lifestyle intervention strategies targeting weight outcomes in people with psychosis: a systematic review and network meta-analysis.
    Mucheru D; Hanlon MC; McEvoy M; Thakkinstian A; MacDonald-Wicks L
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1770-1825. PubMed ID: 31343494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Camacho-Gomez M; Castellvi P
    Schizophr Bull; 2020 Jan; 46(1):98-109. PubMed ID: 31050757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
    McGorry PD; Nelson B; Amminger GP; Bechdolf A; Francey SM; Berger G; Riecher-Rössler A; Klosterkötter J; Ruhrmann S; Schultze-Lutter F; Nordentoft M; Hickie I; McGuire P; Berk M; Chen EY; Keshavan MS; Yung AR
    J Clin Psychiatry; 2009 Sep; 70(9):1206-12. PubMed ID: 19573499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.
    van der Gaag M; Smit F; Bechdolf A; French P; Linszen DH; Yung AR; McGorry P; Cuijpers P
    Schizophr Res; 2013 Sep; 149(1-3):56-62. PubMed ID: 23870806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial.
    Ising HK; Smit F; Veling W; Rietdijk J; Dragt S; Klaassen RM; Savelsberg NS; Boonstra N; Nieman DH; Linszen DH; Wunderink L; van der Gaag M
    Psychol Med; 2015 May; 45(7):1435-46. PubMed ID: 25330734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Effects of Mindfulness-Based Intervention in Patients With First Episode Psychosis and in Individuals With Ultra-High Risk for Transition to Psychosis: A Review.
    Vignaud P; Reilly KT; Donde C; Haesebaert F; Brunelin J
    Front Psychiatry; 2019; 10():797. PubMed ID: 31736811
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
    Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness and feasibility of preventive interventions for psychoses].
    Dorofeikova MV; Petrova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8):108-112. PubMed ID: 31626178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
    Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD
    Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
    McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
    J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critique of the "ultra-high risk" and "transition" paradigm.
    van Os J; Guloksuz S
    World Psychiatry; 2017 Jun; 16(2):200-206. PubMed ID: 28498576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.